We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal

Download Mobile App




Events

31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

3D Bioprinting Rebuilds the Human Heart

By HospiMedica International staff writers
Posted on 13 Aug 2019
Print article
Image: A trileaflet heart valve 3D printed using FRESH (Photo courtesy of CMU).
Image: A trileaflet heart valve 3D printed using FRESH (Photo courtesy of CMU).
A new study describes a collagen scaffold tissue engineering technique that brings us one step closer to being able to three-dimensionally (3D) print a full-sized, adult human heart.

Developed by researchers at Carnegie Mellon University (CMU; Pittsburgh, PA, USA), the technique, called freeform reversible embedding of suspended hydrogels (FRESH), allows collagen to be deposited layer-by-layer within a the hydrogel support bath, giving it a chance to solidify in place before it is removed. Controlling the pH-driven gelation provides a 20-micrometer filament resolution porous microstructure that enables rapid cellular infiltration and micro-vascularization, allowing the fabrication and perfusion of multiscale vasculature and tri-leaflet valves.

The FRESH support gel is easily melted away by heating it from room temperature to body temperature after printing is completed, without damaging the 3D printed collagen structure or the cells. The 3D-bioprinted collagen scaffold can be used to engineer components of the human heart at various scales, from capillaries to a full organ, with high fidelity and function. For the study, cardiac ventricles printed using human cardiomyocytes demonstrated synchronized contractions, directional action potential propagation, and wall thickening up to 14% during peak systole. The study was published on August 2, 2019, in Science.

“Collagen is an extremely desirable biomaterial to 3D print with because it makes up literally every single tissue in your body. What makes it so hard to 3D print, however, is that it starts out as a fluid; so if you try to print this in air it just forms a puddle on your build platform,” said co-lead author PhD student Andrew Hudson, MSc. “We've developed a technique that prevents it from deforming. What we're talking about is the convergence of technologies in the areas of stem cell science, machine learning, and computer simulation, as well as new 3D bioprinting hardware and software.”

Collagen is an ideal material for biofabrication due to its critical role in the extracellular matrix (ECM), where it provides mechanical strength, enables structural organization of cell and tissue compartments, and serves as a depot for cell adhesion and signaling molecules. However, it is difficult to 3D-bioprint complex scaffolds using collagen in its native unmodified form because gelation is typically achieved using thermally driven self-assembly, which is difficult to control.

Related Links:
Carnegie Mellon University

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Orthopedic Extension
AMSCO

Print article

Channels

Critical Care

view channel
Image: Peerbridge Cor is a 3-lead, 2-channel wireless AECG that simplifies the testing and diagnostic process (Photo courtesy of Peerbridge Health)

First-of-its-Kind Trial to Measure Ejection Fraction Severity Directly from AI-Enabled Remote ECG Wearable

Echocardiograms are a standard diagnostic tool to measure ejection fraction but require a clinical setting for administration. This can pose challenges such as scheduling delays, staffing shortages, accessibility... Read more

Surgical Techniques

view channel
Image: Fixation screws for ligament to bone repair (Photo courtesy of 4D Medicine)

Novel Biomaterial Platform Opens Up New Possibilities for Implants and Devices

Resorbable biomaterials, crucial for implantable medical devices, have seen little innovation over decades. Materials like Polylactic Acid (PLA), Polycaprolactone (PCL), and Poly Lactic-co-Glycolic Acid... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more

Business

view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.